<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">genort</journal-id><journal-title-group><journal-title xml:lang="ru">Гений ортопедии</journal-title><trans-title-group xml:lang="en"><trans-title>Genij Ortopedii</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1028-4427</issn><issn pub-type="epub">2542-131X</issn><publisher><publisher-name>ЦЕНТР ИЛИЗАРОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18019/1028-4427-2023-29-4-382-387</article-id><article-id custom-type="edn" pub-id-type="custom">IUGIXQ</article-id><article-id custom-type="elpub" pub-id-type="custom">genort-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>Диагностическая значимость лимфоцитарно-моноцитарного индекса при контрактуре Дюпюитрена</article-title><trans-title-group xml:lang="en"><trans-title>Diagnostic signiffcance of the lymphocyte-monocyte index in Dupuytren's contracture</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щудло</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shchudlo</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Анатольевна Щудло – доктор медицинских наук, ведущий научный сотрудник экспериментальной лаборатории</p><p>Курган</p></bio><bio xml:lang="en"><p>Natalya A. Shchudlo – Doctor of Medical Sciences, Leading Researcher of the Experimental Laboratory</p><p>Kurgan</p></bio><email xlink:type="simple">nshchudlo@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сбродова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sbrodova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Людмила Ивановна Сбродова – кандидат биологических наук, научный сотрудник</p><p>Курган</p></bio><bio xml:lang="en"><p>Lyudmila I. Sbrodova – Candidate of Biological Sciences, Researcher</p><p>Kurgan</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Останина</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostanina</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дарья Андреевна Останина – врач травматолог-ортопед</p><p>Курган</p></bio><bio xml:lang="en"><p>Daria A. Ostanina – Traumatologist-orthopedist</p><p>Kurgan</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр травматологии и ортопедии имени академика Г.А. Илизарова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ilizarov National Medical Research Centre for Traumatology and Orthopedics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2023</year></pub-date><volume>29</volume><issue>4</issue><fpage>382</fpage><lpage>387</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Щудло Н.А., Сбродова Л.И., Останина Д.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Щудло Н.А., Сбродова Л.И., Останина Д.А.</copyright-holder><copyright-holder xml:lang="en">Shchudlo N.A., Sbrodova L.I., Ostanina D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ilizarov-journal.com/jour/article/view/9">https://www.ilizarov-journal.com/jour/article/view/9</self-uri><abstract><sec><title>Введение</title><p>Введение. Данные мировой литературы свидетельствуют о вовлечённости клеток воспалительного ряда в патогенез ладонного фасциального фиброматоза, однако данные о возможных изменениях лейкоцитарных индексов периферической крови у пациентов с контрактурой Дюпюитрена (КД) в сравнении со здоровыми людьми отсутствуют.</p></sec><sec><title>Цель</title><p>Цель. Оценка диагностической значимости нейтрофильно-лимфоцитарного (N/L) и лимфоцитарно-моноцитарного (L/M) индексов периферической крови у пациентов c КД.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Ретроспективно изучены 162 истории болезни пациентов, поступивших на оперативное лечение. Для сравнения результатов анализов периферической крови с нормой использовали анонимизированные лейкоцитограммы 110 условно здоровых лиц (контроль).</p></sec><sec><title>Результаты</title><p>Результаты. В группе здоровых людей и у пациентов с КД выражен половой диморфизм абсолютного содержания нейтрофилов. У мужчин с КД установлено статистически значимое снижение абсолютного содержания лимфоцитов (p = 0,05), а у женщин – достоверное повышение абсолютного содержания моноцитов (p = 0,00) по сравнению с контролем, при этом у больных с КД отсутствует связанная с полом разница этих показателей, характерная для здоровых людей. N/L повышен у мужчин с КД по сравнению с контролем (p = 0,05) и подгруппой женщин с КД (p = 0,01), но по результатам ROC- анализа N/L оказался диагностически бесполезным. Для модели «L/M – степень контрактуры» AUC 0,945, CI 0,918-0,970, p = 0, Se 90,12, Sp 93,21; оптимальный порог L/M 3,102. У пациентов с низким L/M (≤ 3,0) частота поражения обеих кистей и частота контрактур III-IV степени больше на 27,75 % (p = 0,02) и 27,15 % (p = 0,03) соответственно, чем в подгруппе с высоким L/M.</p></sec><sec><title>Обсуждение</title><p>Обсуждение. Разнонаправленность изменений содержания лимфоцитов и моноцитов у мужчин и женщин согласуется с известными из литературы сведениями о дуальных гендер- специфичных путях регуляции иммунной системы у здоровых людей и у пациентов с различными заболеваниями.</p></sec><sec><title>Заключение</title><p>Заключение. По данным исследованной выборки пациентов, лимфоцитарно-моноцитарный индекс является полезным дополнительным лабораторным показателем для выделения группы риска тяжёлого течения фасциального фиброматоза, который без дополнительных затрат может использоваться в клинической практике наряду с известными критериями для выделения группы риска прогрессирования контрактуры Дюпюитрена.</p></sec></abstract><trans-abstract xml:lang="en"><p>Introduction World literature data indicate the involvement of inflammatory cells in the pathogenesis of palmar fascial fibromatosis. However, there are no data on possible changes in peripheral blood leukocyte indices in patients with Dupuytren's contracture (DC) in comparison with healthy people.</p><p>Aim To assess the diagnostic significance of neutrophil-lymphocyte (N/L) and lymphocyte-monocyte (L/M) indices of peripheral blood in patients with CD.</p><p>Materials and methods 162 medical records of patients admitted for surgical treatment were retrospectively studied. To compare the results of their peripheral blood tests with the norm, anonymous leukocytograms of 110 apparently healthy individuals (control) were used.</p><p>Results In the group of healthy people and in patients with DC, sexual dimorphism of the absolute content of neutrophils was expressed. In DC males, a statistically significant decrease in the absolute content of lymphocytes (p = 0.05) was found, and in females, a significant increase in the absolute content of monocytes (p = 0.00) compared with the control, while in patients with DC there was no gender-related difference in these indicators, typical for healthy people. N/L ratio was elevated in DC males compared with controls (p = 0.05) and a subgroup of DC females (p = 0.01), but according to the results of ROC analysis, N/L ratio turned out to be diagnostically useless. For the model "L/M – degree of contracture" AUC 0.945, CI 0.918-0.970, p = 0, Se 90.12, Sp 93.21; optimal threshold L/M 3.102. In patients with low L/M (≤ 3.0), the frequency of lesions in both hands and the frequency of grade III-IV contractures are higher by 27.75 % (p = 0.02) and 27.15 % (p = 0.03), respectively than in the high L/M subgroup.</p><p>Discussion The multidirectional changes in the content of lymphocytes and monocytes in males and females is consistent with the literature data on dual gender-specific ways of regulating the immune system in healthy people and in patients with various diseases.</p><p>Conclusion The findings of the studied sample of patients show that the lymphocyte-monocyte index is a useful additional laboratory indicator for identifying a risk group for severe fascial fibromatosis. It can be used in clinical practice at no additional cost along with the well-known Dupuytren diathesis criteria to identify a risk group for progression of Dupuytren's contracture.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>контрактура Дюпюитрена</kwd><kwd>диагностика</kwd><kwd>нейтрофильно-лимфоцитарный индекс</kwd><kwd>лимфоцитарно-моноцитарный индекс</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Dupuytren's contracture</kwd><kwd>diagnosis</kwd><kwd>neutrophil-lymphocyte index</kwd><kwd>lymphocyte-monocyte index</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Meyerding HW, Black JR, Broders AC. The etiology and pathology of Dupuytren’s contracture. Surg Gynecol Obstet. 1941;72(3):582-590.</mixed-citation><mixed-citation xml:lang="en">Meyerding HW, Black JR, Broders AC. The etiology and pathology of Dupuytren’s contracture. Surg Gynecol Obstet. 1941;72(3):582-590.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Vi L, Gan BS, O'Gorman DB. The potential roles of cell migration and extra-cellular matrix interactions in Dupuytren's disease progression and recurrence. Med Hypotheses. 2010;74(3):510-512. doi: 10.1016/j.mehy.2009.10.009</mixed-citation><mixed-citation xml:lang="en">Vi L, Gan BS, O'Gorman DB. The potential roles of cell migration and extra-cellular matrix interactions in Dupuytren's disease progression and recurrence. Med Hypotheses. 2010;74(3):510-512. doi: 10.1016/j.mehy.2009.10.009</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Salari N, Heydari M, Hassanabadi M, et al. The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and metaanalysis. J Orthop Surg Res. 2020;15(1):495. doi: 10.1186/s13018-020-01999-7</mixed-citation><mixed-citation xml:lang="en">Salari N, Heydari M, Hassanabadi M, et al. The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and metaanalysis. J Orthop Surg Res. 2020;15(1):495. doi: 10.1186/s13018-020-01999-7</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Murphey MD, Fairbairn KJ, Parman LM, et al. From the archives of the AFIP. Musculoskeletal angiomatous lesions: radiologic-pathologic correlation. Radiographics. 1995;15(4):893-917. doi: 10.1148/radiographics</mixed-citation><mixed-citation xml:lang="en">Murphey MD, Fairbairn KJ, Parman LM, et al. From the archives of the AFIP. Musculoskeletal angiomatous lesions: radiologic-pathologic correlation. Radiographics. 1995;15(4):893-917. doi: 10.1148/radiographics</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kraus R, Alzen G, Dreyer T, et al. Morbus dupuytren im kindesalter - fallbericht und literaturrecherche [Dupuytren's disease in children - case report and literature review]. Handchir Mikrochir Plast Chir. 2012;44(3):175-7. (In German) doi: 10.1055/s-0032-1312655</mixed-citation><mixed-citation xml:lang="en">Kraus R, Alzen G, Dreyer T, et al. Morbus dupuytren im kindesalter - fallbericht und literaturrecherche [Dupuytren's disease in children - case report and literature review]. Handchir Mikrochir Plast Chir. 2012;44(3):175-7. (In German) doi: 10.1055/s-0032-1312655</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nordenskjöld J, Englund M, Zhou C, Atroshi I. Prevalence and incidence of doctor-diagnosed Dupuytren's disease: a population-based study. J Hand Surg Eur Vol. 2017;42(7):673-677. doi: 10.1177/1753193416687914</mixed-citation><mixed-citation xml:lang="en">Nordenskjöld J, Englund M, Zhou C, Atroshi I. Prevalence and incidence of doctor-diagnosed Dupuytren's disease: a population-based study. J Hand Surg Eur Vol. 2017;42(7):673-677. doi: 10.1177/1753193416687914</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Diep GK, Agel J, Adams JE. Prevalence of palmar fibromatosis with and without contracture in asymptomatic patients. J Plast Surg Hand Surg. 2015;49(4):247-250. doi: 10.3109/2000656X.2015.1034724</mixed-citation><mixed-citation xml:lang="en">Diep GK, Agel J, Adams JE. Prevalence of palmar fibromatosis with and without contracture in asymptomatic patients. J Plast Surg Hand Surg. 2015;49(4):247-250. doi: 10.3109/2000656X.2015.1034724</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ball C, Izadi D, Verjee LS, et al. Systematic review of non-surgical treatments for early dupuytren's disease. BMC Musculoskelet Disord. 2016;17(1):345. doi: 10.1186/s12891-016-1200-y</mixed-citation><mixed-citation xml:lang="en">Ball C, Izadi D, Verjee LS, et al. Systematic review of non-surgical treatments for early dupuytren's disease. BMC Musculoskelet Disord. 2016;17(1):345. doi: 10.1186/s12891-016-1200-y</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Denkler KA, Park KM, Alser O. Treatment Options for Dupuytren's Disease: Tips and Tricks. Plast Reconstr Surg Glob Open. 2022;10(1):e4046. doi: 10.1097/GOX.0000000000004046</mixed-citation><mixed-citation xml:lang="en">Denkler KA, Park KM, Alser O. Treatment Options for Dupuytren's Disease: Tips and Tricks. Plast Reconstr Surg Glob Open. 2022;10(1):e4046. doi: 10.1097/GOX.0000000000004046</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Müller-Seubert W, Cai A, Arkudas A, et al. A Personalized Approach to Treat Advanced Stage Severely Contracted Joints in Dupuytren's Disease with a Unique Skeletal Distraction Device-Utilizing Modern Imaging Tools to Enhance Safety for the Patient. J Pers Med. 2022;12(3):378. doi: 10.3390/jpm12030378</mixed-citation><mixed-citation xml:lang="en">Müller-Seubert W, Cai A, Arkudas A, et al. A Personalized Approach to Treat Advanced Stage Severely Contracted Joints in Dupuytren's Disease with a Unique Skeletal Distraction Device-Utilizing Modern Imaging Tools to Enhance Safety for the Patient. J Pers Med. 2022;12(3):378. doi: 10.3390/jpm12030378</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dutta A, Jayasinghe G, Deore S, et al. Dupuytren's Contracture - Current Concepts. J Clin Orthop Trauma. 2020;11(4):590-596. doi: 10.1016/j.jcot.2020.03.026</mixed-citation><mixed-citation xml:lang="en">Dutta A, Jayasinghe G, Deore S, et al. Dupuytren's Contracture - Current Concepts. J Clin Orthop Trauma. 2020;11(4):590-596. doi: 10.1016/j.jcot.2020.03.026</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Satish L, Gallo PH, Baratz ME, et al. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts. BMC Musculoskelet Disord. 2011;12:113. doi: 10.1186/1471-2474-12-113</mixed-citation><mixed-citation xml:lang="en">Satish L, Gallo PH, Baratz ME, et al. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts. BMC Musculoskelet Disord. 2011;12:113. doi: 10.1186/1471-2474-12-113</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">van Beuge MM, Ten Dam EJ, Werker PM, Bank RA. Matrix and cell phenotype differences in Dupuytren's disease. Fibrogenesis Tissue Repair. 2016;9:9. doi: 10.1186/s13069-016-0046-0</mixed-citation><mixed-citation xml:lang="en">van Beuge MM, Ten Dam EJ, Werker PM, Bank RA. Matrix and cell phenotype differences in Dupuytren's disease. Fibrogenesis Tissue Repair. 2016;9:9. doi: 10.1186/s13069-016-0046-0</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mayerl C, Del Frari B, Parson W, et al. Characterisation of the inflammatory response in Dupuytren's disease. J Plast Surg Hand Surg. 2016;50(3):171- 9. doi: 10.3109/2000656X.2016.1140054</mixed-citation><mixed-citation xml:lang="en">Mayerl C, Del Frari B, Parson W, et al. Characterisation of the inflammatory response in Dupuytren's disease. J Plast Surg Hand Surg. 2016;50(3):171- 9. doi: 10.3109/2000656X.2016.1140054</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Щудло НА, Варсегова ТН, Ступина ТА, Щудло ММ. Типы и стадии сосудистого ремоделирования при контрактуре Дюпюитрена (анализ 506 артерий в операционном материале 111 пациентов). Гений ортопедии. 2020;26(2):179-184. doi: 10.18019/1028-4427-2020-26-2-179-184</mixed-citation><mixed-citation xml:lang="en">Shchudlo NA, Varsegova TN, Stupina TA, Shchudlo MM. Types and stages of vascular remodeling in Dupuytren's contracture (analysis of 506 arteries in the surgical material of 111 patients). Genij Ortopedii. 2020;26(2):179-184. doi: 10.18019/1028-4427-2020-26-2-179-184</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Щудло Н.А., Костин В.В. Патогенез нейропатии при контрактуре Дюпюитрена. Гений ортопедии. 2019;25(1):58-64. doi: 10.18019/1028-4427-2019-25-1-58-64</mixed-citation><mixed-citation xml:lang="en">Shchudlo NA, Kostin VV. Pathogenesis of neuropathy in Dupuytren's contracture. Genij Ortopedii. 2019;25(1):58-64. doi: 10.18019/1028-4427-2019-25-1-58-64</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Andrew JG, Andrew SM, Ash A, Turner B. An investigation into the role of inflammatory cells in Dupuytren's disease. J Hand Surg Br. 1991;16(3):267-271. doi: 10.1016/0266-7681(91)90051-o</mixed-citation><mixed-citation xml:lang="en">Andrew JG, Andrew SM, Ash A, Turner B. An investigation into the role of inflammatory cells in Dupuytren's disease. J Hand Surg Br. 1991;16(3):267-271. doi: 10.1016/0266-7681(91)90051-o</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gudmundsson KG, Arngrímsson R, Arinbjarnarson S, et al. T-and B-lymphocyte subsets in patients with Dupuytren's disease. Correlations with disease severity. J Hand Surg Br. 1998;23(6):724-7. doi: 10.1016/s0266-7681(98)80083-1</mixed-citation><mixed-citation xml:lang="en">Gudmundsson KG, Arngrímsson R, Arinbjarnarson S, et al. T-and B-lymphocyte subsets in patients with Dupuytren's disease. Correlations with disease severity. J Hand Surg Br. 1998;23(6):724-7. doi: 10.1016/s0266-7681(98)80083-1</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia Rojo E, García Gómez B, Santos-Pérez de la Blanca R, et al. Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Peyronie's disease: a new diagnostic approach to predict the stage of the disease? Asian J Androl. 2021;23(3):325-329. doi: 10.4103/aja.aja_74_20</mixed-citation><mixed-citation xml:lang="en">Garcia Rojo E, García Gómez B, Santos-Pérez de la Blanca R, et al. Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Peyronie's disease: a new diagnostic approach to predict the stage of the disease? Asian J Androl. 2021;23(3):325-329. doi: 10.4103/aja.aja_74_20</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Zhang Y, Zhao G, et al. Difference in Leukocyte Composition between Women before and after Menopausal Age, and Distinct Sexual Dimorphism. PLoS One. 2016;11(9):e0162953. doi: 10.1371/journal.pone.0162953</mixed-citation><mixed-citation xml:lang="en">Chen Y, Zhang Y, Zhao G, et al. Difference in Leukocyte Composition between Women before and after Menopausal Age, and Distinct Sexual Dimorphism. PLoS One. 2016;11(9):e0162953. doi: 10.1371/journal.pone.0162953</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ruettermann M, Hermann RM, Khatib-Chahidi K, Werker PMN. Dupuytren's Disease-Etiology and Treatment. Dtsch Arztebl Int. 2021;118(46):781- 788. doi: 10.3238/arztebl.m2021.0325</mixed-citation><mixed-citation xml:lang="en">Ruettermann M, Hermann RM, Khatib-Chahidi K, Werker PMN. Dupuytren's Disease-Etiology and Treatment. Dtsch Arztebl Int. 2021;118(46):781- 788. doi: 10.3238/arztebl.m2021.0325</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hueston J.T. Dupuytren diathesis. In: McFarlane RM, McGrouther DA, Flint M, eds. Dupuytren’s Disease Biology and Treatment. Edinburgh: Churchill Livingstone; 1990:246-252.</mixed-citation><mixed-citation xml:lang="en">Hueston J.T. Dupuytren diathesis. In: McFarlane RM, McGrouther DA, Flint M, eds. Dupuytren’s Disease Biology and Treatment. Edinburgh: Churchill Livingstone; 1990:246-252.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Abe Y, Rokkaku T, Ofuchi S, et al. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg Br. 2004;29(5):427-30. doi: 10.1016/j.jhsb.2004.06.004</mixed-citation><mixed-citation xml:lang="en">Abe Y, Rokkaku T, Ofuchi S, et al. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg Br. 2004;29(5):427-30. doi: 10.1016/j.jhsb.2004.06.004</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hindocha S, Stanley JK, Watson S, Bayat A. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am. 2006;31(10):1626-34. doi: 10.1016/j.jhsa.2006.09.006</mixed-citation><mixed-citation xml:lang="en">Hindocha S, Stanley JK, Watson S, Bayat A. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am. 2006;31(10):1626-34. doi: 10.1016/j.jhsa.2006.09.006</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Werker P., Dias J., Eaton C., eds. Dupuytren disease and related diseases - The cutting edge. Springer. 2017:450. doi: 10.1007/978-3-319-32199-8</mixed-citation><mixed-citation xml:lang="en">Werker P, Dias J, Eaton C, eds. Dupuytren disease and related diseases - The cutting edge. Springer. 2017:450. doi: 10.1007/978-3-319-32199-8</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Li P, Li H, Ding S, Zhou J. NLR, PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma. Am J Transl Res. 2022;14(5):3017-3027.</mixed-citation><mixed-citation xml:lang="en">Li P, Li H, Ding S, Zhou J. NLR, PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma. Am J Transl Res. 2022;14(5):3017-3027.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Romano A, Laura Parrinello N, Cerchione C, et al. The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents. Blood Cancer J. 2017;7(12):649. doi: 10.1038/s41408-017-0019-6</mixed-citation><mixed-citation xml:lang="en">Romano A, Laura Parrinello N, Cerchione C, et al. The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents. Blood Cancer J. 2017;7(12):649. doi: 10.1038/s41408-017-0019-6</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Miyahara Y, Takashi S, Shimizu Y, Ohtsuka M. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer. World J Surg Oncol. 2020;18(1):78. doi: 10.1186/s12957-020-01847-2</mixed-citation><mixed-citation xml:lang="en">Miyahara Y, Takashi S, Shimizu Y, Ohtsuka M. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer. World J Surg Oncol. 2020;18(1):78. doi: 10.1186/s12957-020-01847-2</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Y, Liu Y, Mo G, et al. Inflammation Markers Have Important Value in Predicting Relapse in Patients with papillary thyroid carcinoma: A Long-Term Follow-Up Retrospective Study. Cancer Control. 2022;29:10732748221115236. doi: 10.1177/10732748221115236</mixed-citation><mixed-citation xml:lang="en">Huang Y, Liu Y, Mo G, et al. Inflammation Markers Have Important Value in Predicting Relapse in Patients with papillary thyroid carcinoma: A Long-Term Follow-Up Retrospective Study. Cancer Control. 2022;29:10732748221115236. doi: 10.1177/10732748221115236</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Berghella AM, Contasta I, Del Beato T, Pellegrini P. The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. Immun Ageing. 2012;9(1):24. doi: 10.1186/1742-4933-9-24</mixed-citation><mixed-citation xml:lang="en">Berghella AM, Contasta I, Del Beato T, Pellegrini P. The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. Immun Ageing. 2012;9(1):24. doi: 10.1186/1742-4933-9-24</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia Rojo E, García Gómez B, Santos-Pérez de la Blanca R, et al. Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Peyronie's disease: a new diagnostic approach to predict the stage of the disease? Asian J Androl. 2021;23(3):325-329. doi: 10.4103/aja.aja_74_20</mixed-citation><mixed-citation xml:lang="en">Garcia Rojo E, García Gómez B, Santos-Pérez de la Blanca R, et al. Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Peyronie's disease: a new diagnostic approach to predict the stage of the disease? Asian J Androl. 2021;23(3):325-329. doi: 10.4103/aja.aja_74_20</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Özbir S, Değirmentepe RB, Atalay HA, et al. The role of inflammatory parameters (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-eosinophil ratio) in patients with Peyronie's disease. Andrology. 2020;8(2):348-352. doi: 10.1111/andr.12702</mixed-citation><mixed-citation xml:lang="en">Özbir S, Değirmentepe RB, Atalay HA, et al. The role of inflammatory parameters (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-eosinophil ratio) in patients with Peyronie's disease. Andrology. 2020;8(2):348-352. doi: 10.1111/andr.12702</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Greenberg JW, Kim J, Pincus J, et al. Are neutrophil-lymphocyte and platelet-lymphocyte ratios useful for determining active phase of Peyronie’s disease? Journal of Clinical Urology. 2022;0(0). doi: 10.1177/20514158221094636</mixed-citation><mixed-citation xml:lang="en">Greenberg JW, Kim J, Pincus J, et al. Are neutrophil-lymphocyte and platelet-lymphocyte ratios useful for determining active phase of Peyronie’s disease? Journal of Clinical Urology. 2022;0(0). doi: 10.1177/20514158221094636</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Eftimie G, Eftimie R. Quantitative predictive approaches for Dupuytren disease: a brief review and future perspectives. Math Biosci Eng. 2022;19(3):2876-2895. doi: 10.3934/mbe.2022132</mixed-citation><mixed-citation xml:lang="en">Eftimie G, Eftimie R. Quantitative predictive approaches for Dupuytren disease: a brief review and future perspectives. Math Biosci Eng. 2022;19(3):2876-2895. doi: 10.3934/mbe.2022132</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Plander M, Salamon A, Toldy E, et al. Cellular immune response in Dupuytren’s disease. Biochemia Medica. 2008;18(2):193-200.</mixed-citation><mixed-citation xml:lang="en">Plander M, Salamon A, Toldy E, et al. Cellular immune response in Dupuytren’s disease. Biochemia Medica. 2008;18(2):193-200.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
